Haemato AG

Research Haemato AG (HAEK) on Bullrun: market cap EUR 69.71M, P/E 5.8, dividend yield 0.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHAEK
• ExchangeHM
• CountryGermany
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 69.71M
• P/E5.8
• Dividend yield0.3%
• Financial periodFY2022
• RevenueEUR 248.14M
• Revenue growth-12.9%
• Net incomeEUR 8.19M
• Free cash flowEUR 18.64M
• Gross margin8.7%

Valuation Snapshot

latest market cap is EUR 69.71M; P/E is 5.8; dividend yield is 0.3%.

About Haemato AG

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases.

Frequently asked questions

What is Haemato AG's market cap?

Haemato AG's market capitalization is EUR 69.71M.

What is Haemato AG's P/E ratio?

Haemato AG's price-to-earnings (P/E) ratio is 5.8.

Does Haemato AG pay a dividend?

Haemato AG has a dividend yield of 0.3%.

What does Haemato AG do?

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments.